The current study is interested in the study of the effect of ellagic acid on levels of glucose and albumin for diabetics of type 1. The target blood samples were collected from 52 diabetics’ type 1 (female and male). For each collected sample, the levels of glucose and albumin were firstly measured and the obtained read was recorded as a control read. A solution of ellagic acid (45 µL) was then added and the resulting solution was then incubated at 37 oC for 45, followed by measuring the levels of glucose and albumin. The same sample was then incubated again at 37 oC for further 45 minutes and the levels of glucose and albumin were then measured. For both incubation times, the obtained results showed that the addition of ellagic acid reduced the levels of glucose and albumin. Furthermore, varietal differences were observed in the levels of glucose and albumin depending on the incubation time. In addition, all obtained reads were studied statistically as a function for some risk factors such as age, weight, and gender.